TMS Co., Ltd. (JP:4891) has released an update. TMS Co., Ltd., a clinical-stage biopharmaceutical company, is making strides with its promising lead program, TMS-007, aimed at treating acute ischemic ...
TMS Co., Ltd. (JP:4891) has released an update. TMS Co., Ltd. has announced the publication of Phase 2a clinical trial results for JX10 (TMS-007), a potential treatment for acute ischemic stroke, in a ...
A clinic in Bellevue talks about transcranial magnetic stimulation. The new technology is becoming more widely available to ...
Moment of Clarity has published a new resource, “TMS Therapy Success Rate for Patients“, offering an in-depth exploration of how transcranial magnetic stimulation (TMS) has improved mental health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback